Intensity-modulated radiation therapy (IMRT) for sarcoma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 26 Feb 2020: Trial started, NCT04288375
  2. 28 Feb 2020: Trial registered, NCT04288375

The trials

NCT04288375: Dose Reduction of Postoperative Radiation for Soft Tissue Sarcoma of the Arms and Legs

State
Under way
Phase
Phase 2
People
65 taking part
Started
26 Feb 2020
Primary completion
Feb 2027
Arms
extremity soft tissue sarcoma (STS)
Results
None posted
  1. 26 Feb 2020: Trial started
  2. 28 Feb 2020: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.